School of Medicine
Showing 1,301-1,350 of 5,161 Results
-
Carl Feinstein
Member, Bio-X
Current Research and Scholarly InterestsAutism and Asperger's Disorder.
Genetically-based neurodevelopmental disorder, including Velocardiofacial Syndrome, Smith-Magenis Syndrome, Williams Syndrome, and Fragile X Syndrome.
Intellectual Disability (mental retardation) and psychiatric disorders.
Developmental Language Disorder and Learning Disabilities.
Sensory impairment in children, including visual and hearing impairment.
Psychiatric aspects of medical illness and disability in children. -
Jeffrey A. Feinstein, MD, MPH
Dunlevie Family Professor of Pulmonary Vascular Disease and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsResearch interests include (1) computer simulation and modeling of cardiovascular physiology with specific attention paid to congenital heart disease and its treatment, (2) the evaluation and treatment of pulmonary hypertension/pulmonary vascular diseases, and (3) development and testing of medical devices/therapies for the treatment of congenital heart disease and pulmonary vascular diseases.
-
David Feldman
Professor of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus
Current Research and Scholarly InterestsStudies of the role of the vitamin D receptor in the action of 1,25-dihydroxyvitamin D, the active vitamin D hormone. Current efforts are evaluating the vitamin D receptor in breast and prostate cancer, osteoporosis and rickets.
-
Heidi M. Feldman
Professor of Pediatrics (Developmental-Behavioral)
Current Research and Scholarly InterestsMy current research program focuses on infants born preterm, before 32 weeks gestation from two language environments: English and Spanish. The study considers how neurobiological factors, specifically properties of the white matter circuits in the brain, interact with social, psychological, and economic factors to predict language processing efficiency at 18 months of age.
-
Marcus Feldman
Burnet C. and Mildred Finley Wohlford Professor
Current Research and Scholarly InterestsHuman genetic and cultural evolution, mathematical biology, demography of China
-
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.
-
Stephen Felt, DVM, MPH
Professor of Comparative Medicine
Current Research and Scholarly InterestsHis research interests include infectious diseases, particularly zoonoses, and exploring techniques which promote the health and welfare of laboratory animals.
-
Michelle Feltes
Clinical Associate Professor, Emergency Medicine
BioDr Michelle Feltes is a Clinical Assistant Professor of Emergency Medicine. She received her medical degree from Washington University in St Louis and completed residency in the George Washington University Emergency Medicine residency program in Washington DC. She completed the Global EM Fellowship at Stanford and the Masters of Academic Medicine degree at the University of Southern California in 2018. She then stayed on as faculty at Stanford University in the department of Emergency Medicine with a focus on global health. Her academic work focuses on the development of global emergency medicine and medical education.
-
Scott Fendorf
Terry Huffington Professor, Senior Associate Dean for Research, Senior Fellow at the Woods Institute for the Environment and Professor of Photon Science
Current Research and Scholarly InterestsSoil and environmental biogeochemistry
-
Liang Feng
Associate Professor of Molecular and Cellular Physiology and, by courtesy, of Structural Biology
On Partial Leave from 2026-08-01 To 2027-03-31Current Research and Scholarly InterestsWe are interested in the structure, dynamics and function of eukaryotic transport proteins mediating ions and major nutrients crossing the membrane, the kinetics and regulation of transport processes, the catalytic mechanism of membrane embedded enzymes and the development of small molecule modulators based on the structure and function of membrane proteins.
-
Howard H Fenn MD
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioCurrent CV available on request to
hhfenn@aol.com
CLINICAL:
Inpatient psychiatry attending at VA HCS Palo Alto for over 30 years.
Medical Director, Geriatric Psychiatry unit, VA HCSC Palo Alto/Menlo Park for 10 years
Outpatient psychiatrist at Palo Alto Medical foundation/Sutter for 15 years
CURRENT PUBLICATIONS:
Lead Editor, Inpatient Geriatric Psychiatry, Springer, 2019
LEGAL/FORENSIC:
Consultation practice on legal issues and court testimony for >40 years
Expert consultant/witness for Coleman vs. California Department of Corrections for 4 years
Qualified Medical Examiner (QME) for Division of Worker's Compensation for 15 years
Compensation and Pension Unit, VA HCS Palo Alto for 5 years
SEMINAR LEADER:
Psychiatric Issues in Cognitive Impairment -- Stanford/VA Alzheimer's Center (SVAAC)
Legal Aspects of Geriatric Psychiatry (Stanford/VA Geriatric Psychiatry Fellowship
Didactic topics on inpatient psychiatry rotation for Stanford Geriatric Psychiatry fellows
EDUCATIONAL/ADMINISTRATIVE:
Program Director, Stanford/VA Geriatric Psychiatry Fellowship, 3 years
Site Director, Inpatient Psychiatry Rotation/Geriatric Medicine Fellowship --6 years
SCHOLARSHIP:
Lead Editor of textbook, Inpatient Geriatric Psychiatry, published by Springer in 2019.
Slide presentations published by the American Society of Clinical Pharmacology (ASCP), editor Ira Glick, MD, entitled:
--Pharmacological Treatment of PTSD
--Behavioral and Psychological symptoms of Dementia
Chapters, review articles on topics of Medication management for Major Neurocognitive Disorder with Behavioral Disturbance
Chapter in Inpatient Geriatric Psychiatry, in On-Call Geriatric Psychiatry (2016), Springer.
. -
Jessica Ferguson Toll
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Ferguson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have undergone bone marrow or solid organ transplantation and patients with hematologic or solid malignancies on chemotherapy.
-
Anne Fernald
Josephine Knotts Knowles Professor of Human Biology, Emerita
Current Research and Scholarly InterestsWorking with English- and Spanish-learning children from diverse socioeconomic and cultural backgrounds, our research examines the importance of early language experience in supporting language development. We are deeply involved in community-based research in San Jose, designing an innovative parent-engagement program for low-resource Latino families with young children. We are also conducting field studies of beliefs about child development and caregiver-child interaction in rural villages in Senegal. A central goal of this translational research is to help parents understand their vital role in facilitating children’s language and cognitive growth.
-
Russell D. Fernald
Benjamin Scott Crocker Professor of Human Biology, Emeritus
Current Research and Scholarly InterestsIn the course of evolution,two of the strongest selective forces in nature,light and sex, have left their mark on living organisms. I am interested in how the development and function of the nervous system reflects these events. We use the reproductive system to understand how social behavior influences the main system of reproductive action controlled by a collection of cells in the brain containing gonodotropin releasing hormone(GnRH)
-
Nielsen Fernandez-Becker
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI am the director of the Celiac Disease Program at Stanford and I am highly experienced in diagnosis and management of celiac disease and gluten associated disorders.
My objective is to provide excellent and compassionate clinical care for my patients while seeking a better understanding of diseases I treat, particularly Celiac disease (CeD), eosinophilic esophagitis (EoE). My top priorities are patient care and translational research to make new discoveries and improve the care my patients. -
Marcelo Fernandez Vina
Professor of Pathology
BioMarcelo Fernández-Viña, Ph.D., D (ABHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He earned a degree in Biochemistry from the School of Basic Sciences in Rosario, Argentina, and his Ph.D. in Internal Medicine from the University of Buenos Aires Medical School in Argentina. Previously he held a position as a Professor in the Department of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. He has more than 180 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases and in the impact of HLA mismatches in allogeneic transplantation; and 59 book chapters. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR; He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT).He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and Past President of the International HLA & Immunogenetics Workshop.
-
Juan Carlos Fernandez-Miranda, MD, FACS
Professor of Neurosurgery and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Juan Fernandez-Miranda is Professor of Neurosurgery and Surgical Director of the Stanford Brain Tumor, Skull Base, and Pituitary Centers. He is internationally renowned for his expertise in minimally invasive brain surgery, endoscopic skull base and pituitary surgery, open skull base surgery, and complex brain tumor surgery. He has performed over 4,000 cranial operations including more than 2,000 endoscopic endonasal operations for pituitary tumors and other skull base lesions. He is highly regarded for his innovative contributions to the development and refinement of endoscopic endonasal skull base surgery, for his ability to select the most effective and less invasive approach to each individual patient, and for his precise knowledge of the intricate anatomy of the white matter tracts required to maximize resection and minimize morbidity on high and low grade glioma patients. He has been recently ranked by Expertscape as World-Expert (top 0.05%) on Skull Base Surgery and #1 Neurosurgeon Expert on Skull Base Tumors (pituitary adenomas, meningiomas, craniopharyngiomas, chordomas, chondrosarcomas, schwannomas and esthesioneuroblastomas) on the US Pacific Region. He is co-founder and vice-president of the International Rhoton Society and executive member of the Board of Directors of the The Neurosurgical Atlas, the largest nonprofit organization for neurosurgical education and research in the world.
Dr. Fernandez-Miranda completed neurosurgery residency at La Paz University Hospital in Madrid, Spain. Upon completion of his residency, he was awarded the Sanitas Prize to the best medical postgraduate trainee in the country. From 2005 to 2007, he underwent fellowship training in microsurgical neuroanatomy at the University of Florida under legendary neurosurgeon Albert L. Rhoton, Jr. From 2007 to 2010 he continued subspecialty clinical training in cerebrovascular surgery at the University of Virginia, and endoscopic endonasal and open skull base surgery at University of Pittsburgh Medical Center (UPMC). During his 10-year tenure at UPMC, he pioneered endoscopic endonasal approaches to highly complex pituitary and skull base tumors, developed a world-class complex brain surgery program, and led a premier training and research program on surgical neuroanatomy and skull base surgery.
In 2018, he was recruited to bring to Stanford his unique technical expertise and to collaborate with world-renowned Stanford colleagues across multiple disciplines, leading the establishment of one of the most preeminent centers worldwide for comprehensive treatment of complex lesions in the brain, skull base, and pituitary regions. His top priority is to provide gentle, accurate, and safe surgery, in a team-based and compassionate approach to patient care. -
Sebastian Fernandez-Pol
Clinical Associate Professor, Pathology
BioDr. Sebastian Fernandez-Pol is an academic hematopathologist with fellowship training in hematopathology and dermatopathology. He has a particular interest in improving diagnostic accuracy for cutaneous lymphoproliferative disorders. Dr. Fernandez-Pol received his B.A. in chemistry with a concentration in biochemistry from the Washington University in St. Louis in 2003, his MD and PhD from Northwestern University in 2013, and completed his anatomic pathology and clinical pathology residency, hematopathology fellowship, and dermatopathology fellowship at Stanford University in 2019.
-
Katherine Ferrara
Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsMy focus is image-guided drug and gene delivery and I am engaged in the design of imaging devices, molecularly-targeted imaging probes and engineered delivery vehicles, drawing upon my education in biology and imaging physics and more than 20 years of experience with the synthesis and labeling of therapeutic particles. My laboratory has unique resources for and substantial experience in synthetic chemistry and ultrasound, CT, MR and PET imaging.
-
James Ferrell
Professor of Chemical and Systems Biology and of Biochemistry
Current Research and Scholarly InterestsMy lab has two main goals: to understand the regulation of mitosis and to understand the systems-level logic of simple signaling circuits. We often make use of Xenopus laevis oocytes, eggs, and cell-free extracts for both sorts of study. We also carry out single-cell fluorescence imaging studies on mammalian cell lines. Our experimental work is complemented by computational and theoretical studies aimed at understanding the design principles and recurring themes of regulatory circuits.
-
Margaret S. Ferris, MD
Clinical Assistant Professor, Adult Neurology
Clinical Assistant Professor (By courtesy), NeurosurgeryBioDr. Ferris is a fellowship-trained neurologist and Clinical Assistant Professor in the Department of Neurology, Division of Movement Disorders.
She diagnoses and treats a breath of movement disorders such as Parkinson’s disease and essential tremor. She recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.
Dr. Ferris research interests focus on access to interventional therapies for movement disorders. She has participated in investigations sponsored by the National Institutes of to evaluate advanced treatments for complications of Parkinson’s disease.
She has co-authored articles in publications such as Nature, The Neurohospitalist, and BioMed Central (BMC) Genomics. She has presented her insights about innovations in the understanding, detection, and management of movement disorders at conferences including, the Society for Neuroscience Annual Meeting, Pan American Parkinson’s Disease and Movement Disorders Congress.
She is a member of the American Academy of Neurology and the Movement Disorder Society.
Essential tremor patient story: https://www.youtube.com/watch?v=fV6BzyU9b3c -
Nicolas Fesser
Clinical Instructor, Emergency Medicine
BioNico Fesser, MD, is a Global Emergency Medicine Fellow in the Department of Emergency Medicine at Stanford University and a Stanford Global Health Postdoctoral Affiliate with the Center for Innovation in Global Health (CIGH), Stanford's university-wide hub for global health research, education, and training. He completed his residency in Emergency Medicine at the University of Washington, where he received the Resident Peer Recognition Award and the UW Medical Center Martin Luther King Jr. Community Service Award. He earned his MD from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, where he was elected to Alpha Omega Alpha and the Gold Humanism Honor Society and received the Medical Alumni Association Award. He completed his undergraduate studies in Neurobiology, with a minor in Global Health, at the University of Wisconsin–Madison. Born and raised in Madrid, he moved to upstate New York at age fourteen.
Dr. Fesser's interests include global emergency care, humanitarian response, and resource mobilization, particularly within conflict-affected settings. He has worked and collaborated directly within this context with organizations such as the United Nations, the West Africa AIDS Foundation, and Partners In Health. He has also conducted public health projects and worked clinically across much of sub-Saharan Africa, including Ebola response in the Democratic Republic of the Congo (DRC), tuberculosis care in Lesotho, and HIV/AIDS work in Ghana and Tanzania, among others.
A central focus of his work is the rescue, demobilization, and reintegration of children affected by armed conflict in the eastern DRC. In 2020, he founded Fesser and Friends, a nonprofit organization that operates two child rescue and rehabilitation centers in the province of North Kivu and serves as UNICEF's referral center of choice in the region. The center in Beni serves children orphaned by armed conflict, many of them survivors of some of the country's worst mass atrocities. The center in Goma supports the long-term demobilization and reintegration of former child soldiers, many of whom were forced to commit acts of violence themselves. Both provide housing, medical care, education, vocational training, and family reunification services. To date, the organization has reunited hundreds of missing children with their families and has provided over a quarter of a million meals to children and displaced families. He also founded Beyond the Rhythm, a music-based fundraising initiative that helps support some of this work.
His fellowship training combines clinical practice with targeted coursework in tropical medicine, humanitarian operations, nonprofit leadership, and diplomacy. He is currently completing the Diploma in Tropical Medicine and Hygiene at the London School of Hygiene & Tropical Medicine. His planned coursework also includes the Executive Program for Nonprofit Leaders at the Stanford Graduate School of Business and the Health Emergencies in Large Populations (HELP) course at the University of Geneva, developed with the ICRC and WHO. In his second year, he will complete the Certificate in International Relations and Diplomacy at Sciences Po in Paris.
Dr. Fesser works at the intersection of emergency medicine, humanitarian diplomacy, and policy to improve outcomes for children and communities affected by armed conflict. Following his fellowship, he aspires to serve in senior leadership roles within humanitarian and governmental organizations. -
Dorien Feyaerts
Instructor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsBiomedical scientist and immunologist with a strong background in fetal-maternal immunology that aims to conduct impactful translational research in women’s health to improve the health of mothers and their children.
-
Vikram Fielding-Singh, MD, JD
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsImproving perioperative care of patients with end stage kidney disease, using biomarkers to aid early diagnosis of acute kidney injury, and evaluating the performance of risk prediction models in perioperative medicine.
-
Andrey Finegersh, MD, PhD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Finegersh is a fellowship-trained head and neck surgical oncologist with board certification in otolaryngology and an Assistant Professor with the Stanford School of Medicine Department of Otolaryngology.
He specializes in treatment of benign and malignant tumors of the head and neck and has received additional training in microvascular reconstruction and transoral robotic surgery. He takes tremendous pride in providing compassionate care for patients and managing challenging diagnoses.
Dr. Finegersh completed his MD and PhD degrees at the University of Pittsburgh School of Medicine's combined Medical Scientist Training Program. He went on to complete residency in otolaryngology at the University of California San Diego (UCSD) and his fellowship at Stanford University, where he stayed on as faculty.
He has extensive research experience in head and neck cancer epigenetics and completed post-doctoral research at the University of Pittsburgh and UCSD. He has received grants from the NIH and American Academy of Otolaryngology and has an active research lab studying molecular mechanisms of cancer. Dr. Finegersh has additional clinical interests in studying the role of minimally invasive surgery to improve outcomes for head and neck cancer patients. -
Anna Finley Caulfield, MD
Clinical Professor, Adult Neurology
Current Research and Scholarly InterestsDr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.
-
David Fiorentino, MD, PhD
Professor of Dermatology
Current Research and Scholarly InterestsFrom a clinical standpoint, I am particularly focused in the care of patients with myositis or systemic sclerosis. We offer clinical trials, including novel, cutting-edge cellular-based (e.g. chimeric antigen receptor, or, CAR T) therapies for these diseases. We are particularly interested in understanding the role of auto antigens in providing windows into disease pathogenesis, as well as their potential direct role of autoantibodies in causing disease.
-
Andrew Fire
George D. Smith Professor of Molecular and Genetic Medicine and Professor of Pathology and of Genetics
Current Research and Scholarly InterestsWhile chromosomal inheritance provides cells with one means for keeping and transmitting genetic information, numerous other mechanisms have (and remain to be) discovered. We study novel cellular mechanisms that enforce genetic constancy and permit genetic change. Underlying our studies are questions of the diversity of inheritance mechanisms, how cells distinguish such mechanisms as "wanted" versus "unwanted", and of the consequences and applications of such mechanisms in health and disease.
-
Daniel James Firl
Clinical Instructor, Surgery - Abdominal Transplantation
BioDaniel Firl is an abdominal transplant surgery fellow at Stanford Medicine and a surgeon-scientist working at the intersection of hepatobiliary cancer surgery and transplantation. His work centers on patient selection in primary liver cancer — determining which patients are best served by resection and which by transplantation — and on the risk-assessment tools that make that decision more precise.
He is a co-developer of HALT-HCC, a risk model for liver transplantation in hepatocellular carcinoma, and first author of its international validation across more than 4,000 patients. His aim is to make selection between resection and transplantation progressively more sophisticated — sharpening prediction of waitlist and post-transplant outcomes, informing donor selection, and enabling the safe use of grafts that might otherwise be declined — with a particular interest in intrahepatic cholangiocarcinoma and gallbladder cancer, where the role of transplantation is still being defined. He sees the next step as the integration of tumor genomics, bringing the molecular features of each cancer into the models that guide surgical decisions.
Earlier, during postdoctoral training at the Massachusetts General Hospital, he studied the immunology and physiology of kidney xenotransplantation, including the design and long-term function of organs from genetically engineered porcine donors — part of the broader effort to expand the supply of transplantable organs.
Dr. Firl completed general surgery residency at Duke University, where he served as chief resident, and earned his MD with Special Qualifications in Biomedical Research through the research-intensive program at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He holds a bachelor's degree in biochemistry from Boston College.
He is the author of over 30 peer-reviewed articles, with work in Nature, Cell, The Lancet Gastroenterology & Hepatology, Hepatology, and The Lancet Digital Health. He serves as an ad hoc reviewer for journals including The BMJ, Kidney International, the American Journal of Transplantation, JCO Precision Oncology, and Transplantation.
He has received fellowships and grant funding from prestigious organizations during competitive funding opportunities including from: the NIH-NIAID, Howard Hughes Medical Institute, and the American Society of Transplantation.
